Overview

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature

Status:
Unknown status

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature: a clinical trial, randomized, double-blind placebo controlled trial.

Phase:

Phase 3

Details

Lead Sponsor:

Juan A. Arnaiz

Treatments:

Citric Acid
Potassium Citrate